Fons Bosman
9Patents
5h-index
11Co-inventors
52Inventor score
Filing activity: Mar 11, 1996 → Apr 24, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6150134A | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use | Emerging Cross-Sectional Technologies | 16 | Expired |
| US7101561B2 | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use | Chemistry; Metallurgy | 16 | Expired |
| US7238356B2 | Core-glycosylated HCV envelope proteins | Chemistry; Metallurgy | 14 | Expired |
| US7048930B2 | Expression of core-glycosylated HCV envelope proteins in yeast | Chemistry; Metallurgy | 9 | Expired |
| US6890737B1 | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7314925B2 | Constructs and methods for expression of recombinant HCV envelope proteins | Chemistry; Metallurgy | 5 | Expired |
| US6245503A | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7026457B2 | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7108855B2 | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.